Cohance Lifesciences Releases Earnings Conference Call Recording for Q2 & H1 Ended Sep'26
Cohance Lifesciences Ltd 路 Audio / Video 路 07 Nov 2026, 4:35 pm
Cohance Lifesciences Releases Earnings Conference Call Recording for Q2 & H1 Ended Sep'26 Cohance Lifesciences Limited (formerly Suven Pharmaceuticals Limited) has released the audio recording of its earnings conference call for the quarter and half-year ended 30th Sep'26. The conference call was conducted on 6th Nov'26 following its prior intimation on 3rd Nov'26. The complete audio file has been uploaded and is accessible via the company's official website for investor access.
Original exchange filing (PDF)
More announcements from Cohance Lifesciences Ltd
- The Exchange has received the revised disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Jasti Property and Equity Holdings .... 路 12 Nov 2026
- The Exchange has received the revised disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Jasub Property Holdings LLP & Others 路 12 Nov 2026
- Investors Meet 路 11 Nov 2026
- Transcript of Con call 路 11 Nov 2026
- The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Jasub Property Holdings LLP & Others 路 11 Nov 2026
- The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Jasti Property and Equity Holdings Pvt Ltd & Others 路 11 Nov 2026
- Investor Presentation 路 07 Nov 2026
- Update on USFDA inspection at Pashamylaram Manufacturing facility. 路 07 Nov 2026
